Globus Medical is trading with a PEG ratio of 0.08, based on Jun 22, 2026 data. Dividing the 18.2 PE ratio by the 219.9% earnings growth rate yields this valuation metric. Relative to the 0.05 average from the previous four quarters, the PEG ratio has soared by 52%.
Historically, Globus Medical shows a PEG ratio averaging 2.53 across the past ten years. At 0.08, today's PE to growth ratio sits 97% below its historical average. The ten years high occurred in the Sep 2023 quarter at 16.64, reflecting maximum valuation relative to growth. The minimum was hit in the Jun 2025 quarter at 0.02, indicating optimal value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.05 | 21.94 | 423.7% |
| 2024 | N/A | 108.83 | -30.3% |
| 2023 | N/A | 48.89 | -42.3% |
| 2022 | 1.42 | 39.3 | 27.7% |
| 2021 | 1.15 | 48.78 | 42.3% |
| 2020 | N/A | 62.71 | -33.8% |
| 2019 | N/A | 37.5 | -1.9% |
| 2018 | 0.63 | 27.05 | 42.9% |
| 2017 | 13.11 | 36.7 | 2.8% |
| 2016 | N/A | 22.76 | -8.4% |
| 2015 | 1.09 | 23.38 | 21.4% |
| 2014 | 0.75 | 24.26 | 32.4% |
| 2013 | N/A | 27.27 | -9.8% |
| 2012 | 0.68 | 12.79 | 18.8% |
| 2011 | N/A | N/A | 13.1% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.09 | 19.81 | 219.9% |
| Dec 2025 | 0.05 | 21.94 | 423.7% |
| Sep 2025 | 0.05 | 18.3 | 404.8% |
| Jun 2025 | 0.02 | 22.44 | 952% |
| Mar 2025 | 0.41 | 53.82 | 130.5% |
| Dec 2024 | N/A | 108.83 | -30.3% |
| Sep 2024 | N/A | 115.39 | -60.5% |
| Jun 2024 | N/A | 273.96 | -87.7% |
| Mar 2024 | N/A | 90.92 | -70.6% |
| Dec 2023 | N/A | 48.89 | -42.3% |
| Sep 2023 | 16.64 | 31.62 | 1.9% |
| Jun 2023 | 0.88 | 29.19 | 33.3% |
| Mar 2023 | 0.65 | 28.18 | 43.6% |
| Dec 2022 | 1.42 | 39.3 | 27.7% |
| Sep 2022 | N/A | 38.68 | -17.6% |
Measured against past performance, GMED's PEG ratio is below the 3, 5 and 10-year averages.
With a PEG of 0.08, GMED is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.55, Globus Medical's PEG is 85% lower.
GMED has a PEG ratio below that of peer stock SYK.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| GMED Globus Medical Inc | 0.08 | $10.75B |
| SYK Stryker Corp | 2.11 | $116.81B |
| OFIX Orthofix Medical Inc | N/A | $361.77M |
| ATEC Alphatec Holdings Inc | N/A | $1.31B |
Based on Jun 22, 2026 data, GMED carries a PEG ratio of 0.08.
GMED has a 3-year average PEG ratio of 2.59.
GMED has a 5-year average PEG ratio of 2.0.
The Sep 2023 quarter marked the ten years high at 16.64 for GMED's PEG ratio.
Compared to the 10-year average, GMED's PEG ratio is 97% lower.
The 0.08 PEG ratio for GMED reflects strong earnings growth outpacing the current valuation.
To calculate the PEG ratio, take the company's PE ratio and divide by its EPS growth (YoY TTM). As of Jun 22, 2026, Globus Medical has a P/E ratio of 18.2. Earnings grew at 219.9% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 0.08. PEG RATIO(0.08) = PE RATIO(18.2) / EPS GROWTH(219.9%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.